ArticleBioorganic & medicinal chemistry2018

Corrigendum to "Structure-activity study for (bis)ureidopropyl- and (bis)thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architectures" [Bioorg. Med. Chem. 23 (2015) 1601-1612].

Shannon L Nowotarski et al.PubMed ↗Publisher ↗

No numbers read from the abstract.